Molecular Imaging of Precancerous Colorectal Lesions
Abstract Colorectal cancer (CRC) has become the third leading cause of cancer-related deaths in the United States, and the incidence and death rates of the disease in Americans under 50 years-old have risen startlingly in recent years. Critically, however, the 5-year survival rate for CRC is >90% when the disease is detected early, and the malignancy can be avoided completely if lesions are detected while still precancerous. In light of this, the detection of precancerous colorectal lesions i.e. via colonoscopy is absolutely crucial to public health. Molecular imaging can be a valuable clinical tool for the visualization of these premalignant tissues, and modalities such as PET, CT, fluorescence, ultrasound, and photoacoustic imaging have been harnessed to detect lesions that may otherwise be difficult to identify during traditional colonoscopies. In this review, we discuss current challenges in the detection of precancerous colorectal lesions, cover the ways in which molecular imaging is currently deployed in this area, and address emergent technologies that have arisen at the intersection of these two fields.
Authors
- Camilla Grimaldi
- Brian M. Zeglis (ORCID: https://orcid.org/0000-0002-9091-744X)
- Gina Dehlavi
- Erika Patel (ORCID: https://orcid.org/0009-0007-5916-8106)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- City University of New York (US)
- Cornell University (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.6c00896
- Primary Topic
- Optical Imaging and Spectroscopy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases